In 1949, Dr H. Sherwood Lawrence made a very significant discovery. In the process of studying tuberculosis, which was a major health threat at the time, he discovered an immune response could be transferred from a donor to a recipient through an injection of an extract of leukocytes (white blood cells). Further investigation led him to conclude that this immune extract must contain "factors" that made it possible to transfer the donor’s immunity to the recipient. He called these molecules "transfer factors."

In 1989, two researchers completed what was to become a patented process for actually extracting transfer factors from cow colostrum, resulting in a concentrated form. The patent reference is U.S. Patent 4,816,563.

In 1999, the effectiveness and safety of transfer factor supplementation was validated by scores of clinical studies worldwide. Scientists are just beginning to grasp the profound implications of transfer factor therapy in determining the health of not only present, but future generations.

Dr Gary Wilson and Dr Greg Paddock successfully completed a myriad of tests to win USDA approval for their transfer factor technology. It is this unique, patented technology that makes it possible to isolate or to separate transfer factors from cow colostrum. Through this extraction technique, pure transfer factors can be collected from the cow’s first milk, dried and then encapsulated for human consumption.